Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

MENT could be a better option than testosterone for male hormone therapy and birth control because it works well at lower doses and has fewer side effects on the prostate.

Finasteride doesn't improve survival in LNCaP tumor model during off-cycle of therapy.

Cooling the skin before injections reduces pain for patients with hair loss.

The document covers various dermatological treatments and conditions.

The document concludes that breast pain should be managed with personalized treatment, starting with non-drug methods and progressing to medication if necessary, while considering side effects and patient needs.

Teriflunomide is safe and tolerable for treating relapsing-remitting multiple sclerosis, with manageable side effects.

Men with benign prostatic hyperplasia are more likely to have metabolic syndrome than those without it.

COVID-19 may harm male fertility and damage the reproductive system.

The length of CAG repeats in the androgen receptor gene is linked to ovarian reserve but does not affect how the ovaries respond to stimulation.

New acne treatments include combination creams, advanced retinoids, and light therapies, focusing on safety and patient adherence.

New BPH treatments have low sexual dysfunction risk but may not improve urinary symptoms as much as traditional surgery.

Adaptive coping reduces PCOS symptoms, while maladaptive coping worsens them.

The document concludes that better targeted treatments are needed for wound healing, and single-cell technologies may improve cell-based therapies.

Some drugs can cause rare but potentially deadly skin reactions, and early treatment and avoiding the drug again are key.

Artificial skin development has challenges, but new materials and understanding cell behavior could improve tissue repair. Also, certain growth factors and hydrogel technology show promise for advanced skin replacement therapies.

Asia has made significant progress in tissue engineering and regenerative medicine, but wider clinical use requires more development.

Women with PCOS are more than twice as likely to develop nonalcoholic fatty liver disease.

Cancer patients treated with immune checkpoint inhibitors may develop alopecia, but some hair regrowth is possible with treatment.

Skin problems in COVID-19 patients are rare and may be due to the body's complex immune response or blood clotting issues.

The document concludes that minoxidil and finasteride are proven for hair growth, herbal remedies show promise, but more research is needed to confirm their effectiveness.

Many COVID-19 survivors experience long-term symptoms like fatigue and sleep issues, needing ongoing medical support.

Lower levels of certain brain chemicals are linked to worse PTSD symptoms in men.

Graft-versus-host disease is a complication where donor immune cells attack the recipient's body, often affecting the skin, liver, and gastrointestinal tract.

Menopause and aging can affect women's quality of life and sexuality, but hormone therapies may help alleviate these issues.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

Nano-PROTACs could improve drug targeting and delivery by using nanotechnology.

Cannabinoids may help treat chronic and chemotherapy-induced neuropathic pain, but more research is needed to confirm their effectiveness and safety.

Pregnancy can cause normal skin changes that usually go away after childbirth and don't need treatment.

Chitosan microparticles improve minoxidil sulphate delivery, potentially reducing daily applications.

Children generally have milder SARS symptoms than adults, with good outcomes and no deaths reported, but long-term effects are unclear.